Hims & Hers Health, Inc.

About

Hims & Hers is a digital health platform founded in 2017 that connects people to licensed healthcare providers and personalized treatment plans. The company focuses on normalizing health and wellness challenges, providing access to care across various areas including sexual health, hair care, weight loss, and mental health. Hims & Hers aims to empower individuals to take charge of their health through personalized, on-demand care.

Verified company data

Leadership

Andrew Dudum (CEO, Co-founder and entrepreneur with a passion for innovation and accessibility. Previously co-founded Atomic Labs and was named to Fortune’s 40 Under 40 in 2020.), Soleil Boughton (Chief Legal Officer, Over 20 years of healthcare law experience, previously held positions at Google Cloud Healthcare & Life Sciences.), Yemi Okupe (Chief Financial Officer, Extensive financial leadership experience from high-growth B2C companies including Uber, eBay, PayPal, and Google.), Mike Chi (Chief Commercial Officer, Over 20 years of experience in consumer-focused businesses with expertise in brand positioning and growth marketing.), Patrick Carrol, MD (Chief Medical Officer, Extensive leadership in virtual and retail healthcare, overseeing care delivery and clinical outcomes.), Dan Kenger (Chief Design Officer, Over 15 years of experience leading creative teams across design and content.), Mo Elshenawy (Chief Technology Officer, Over 20 years of experience in AI and large-scale infrastructure, previously President and CTO at Cruise.), Dheerja Kaur (Chief Product Officer, Nearly 20 years of experience building consumer-focused products, previously VP of Product at Robinhood.)

Verified data last updated: 2026-10-16

Recent filings

• Statement of changes in beneficial ownership of securities2026-10-15 · hims_2026-10-15_19-44-57.pdf→
• Notice of proposed sale of securities pursuant to Rule 1442026-10-14 · hims_2026-10-14_12-44-33.pdf→
• Current report pursuant to Section 13 or 15(d)2026-10-07 · hims_2026-10-07_19-13-26.pdf→
• Statement of changes in beneficial ownership of securities2026-10-02 · hims_2026-10-02_19-32-05.pdf→
• Notice of proposed sale of securities pursuant to Rule 1442026-10-01 · hims_2026-10-01_15-05-54.pdf→
• Notice of proposed sale of securities pursuant to Rule 1442026-09-30 · hims_2026-09-30_13-31-09.pdf→
• Statement of changes in beneficial ownership of securities2026-09-23 · hims_2026-09-23_19-17-12.pdf→
• Notice of proposed sale of securities pursuant to Rule 1442026-09-22 · hims_2026-09-22_15-12-44.pdf→